Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Acelrx Pharmaceutica
(NQ:
ACRX
)
1.910
USD
-0.060 (-3.05%)
Official Closing Price
Updated: 7:16 PM EST, Mar 2, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Acelrx Pharmaceutica
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AcelRx Pharmaceuticals, Inc. (ACRX)
February 18, 2021
Pomerantz LLP is investigating claims on behalf of investors of AcelRx Pharmaceuticals, Inc. ("AcelRx" or the "Company") (NASDAQ: ACRX). Such investors are advised to contact Robert S. Willoughby at...
From
PR Newswire
AcelRx Announces an Investigator-Initiated Study of DSUVIA® in Patients Undergoing Plastic Surgery Procedures
February 17, 2021
AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in healthcare institutions,...
From
PR Newswire
ROCE Insights For AcelRx Pharmaceuticals
January 26, 2021
During Q3, AcelRx Pharmaceuticals's (NASDAQ:ACRX) reported sales totaled $1.37 million. Despite a 32.24% in earnings, the company ...
Tags
News
Health Care
ACRX
From
Benzinga
68 Biggest Movers From Yesterday
January 21, 2021
Gainers Obalon Therapeutics Inc (NASDAQ: OBLN) shares jumped 414.3% to close at $8.28 on Wednesday after the company announced a ...
Tags
GRTX
HSTO
MARA
From
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
January 20, 2021
Gainers Obalon Therapeutics (NASDAQ:OBLN) shares rose 384.47% to $7.8 during Wednesday's regular session. The ...
Tags
TLSA
Benzinga
ITRM
From
Benzinga
45 Stocks Moving In Wednesday's Mid-Day Session
January 20, 2021
Gainers Obalon Therapeutics Inc (NASDAQ: OBLN) shares jumped 175% to $4.4250 after the company announced a merger agreement with ...
Tags
CLCT
Benzinga
Penny Stocks
From
Benzinga
Why AcelRx Pharmaceuticals Stock Is Sinking Today
January 20, 2021
The company announced the pricing of a public stock offering.
Tags
ACRX
Market News
From
Motley Fool
AcelRx Announces Pricing of $27.5 Million Public Offering of Common Stock
January 20, 2021
AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in healthcare institutions,...
From
PR Newswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
January 20, 2021
Gainers Caladrius Biosciences (NASDAQ:CLBS) shares increased by 118.4% to $3.56 during Wednesday's pre-market ...
Tags
BZI/TFM
BLRX
Movers
From
Benzinga
The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study
January 20, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
CASI
TSHA
DARE
From
Benzinga
40 Stocks Moving in Wednesday's Pre-Market Session
January 20, 2021
Gainers Caladrius Biosciences, Inc. (NASDAQ: CLBS) rose 132.4% to $3.79 in pre-market trading. Caladrius Biosciences said it ...
Tags
VYNE
NFLX
CLBS
From
Benzinga
10 Stocks Moving In Tuesday's After-Hours Session
January 19, 2021
Gainers Netflix (NASDAQ: NFLX) shares are trading higher after the company reported better-than-expected Q4 sales results, issued ...
Tags
News
ROKU
ACRX
From
Benzinga
AcelRx Announces Underwritten Public Offering of Common Stock
January 19, 2021
AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in healthcare institutions,...
From
PR Newswire
Why Is It Moving? Looking Into Why AcelRx Pharmaceuticals's Stock is Trading Higher Today
January 19, 2021
The Price And Volume Action In AcelRx Pharmaceuticals's Stock Today AcelRx Pharmaceuticals's (NASDAQ:ACRX) stock is trading ...
Tags
ACRX
Benzinga
Trading Ideas
From
Benzinga
AcelRx Announces an Investigator-Initiated Study of DSUVIA® in Cardiac Surgery Enhanced Recovery Regimen
January 19, 2021
AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in healthcare institutions,...
From
PR Newswire
Are You Following Analysts On These Penny Stocks?
January 15, 2021
This year has gotten off to a strong start already. Many stocks, including penny stocks, are reaching new 52-week and all-time highs. ...
Tags
Exela Technologies
Synthetic Biologics Inc
Alliance Global
From
Benzinga
Top Penny Stocks To Buy According To 4 Analysts & Targets Up To 265%
January 15, 2021
Tags
Market News
From
Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Interesting ACRX Call Options For September 17th
January 15, 2021
Investors in AcelRx Pharmaceuticals Inc (ACRX) saw new options begin trading this week, for the September 17th expiration. One of the key inputs that goes into the price an option buyer is willing to...
Tags
Stocks
From
Market News Video
AcelRx Announces Year-End 2020 Metrics and Review of 2020 Achievements
January 14, 2021
AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today...
From
PR Newswire
80 Biggest Movers From Yesterday
January 14, 2021
Gainers Live Ventures Incorporated (NASDAQ: LIVE) shares jumped 90.4% to close at $23.90 on Wednesday after the company swung to a ...
Tags
Market News
AFMD
VIRC
From
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
January 13, 2021
Gainers Acorda Therapeutics (NASDAQ:ACOR) stock moved upwards by 33.02% to $5.64 during Wednesday's regular session. ...
Tags
BZI/TFM
STIM
NCNA
From
Benzinga
61 Stocks Moving In Wednesday's Mid-Day Session
January 13, 2021
Gainers Live Ventures Incorporated (NASDAQ: LIVE) shares climbed 101.4% to $25.28 after the company swung to a profit in the ...
Tags
AAPL
Intraday Update
ACOR
From
Benzinga
ROCE Insights For AcelRx Pharmaceuticals
January 13, 2021
During Q3, AcelRx Pharmaceuticals's (NASDAQ:ACRX) reported sales totaled $1.37 million. Despite a 32.24% in earnings, the company ...
Tags
Health Care
News
ACRX
From
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
January 13, 2021
Gainers Acorda Therapeutics (NASDAQ:ACOR) stock increased by 54.24% to $6.54 during Wednesday's pre-market session. ...
Tags
Benzinga
VCNX
Pre/Market Outlook
From
Benzinga
The Daily Biotech Pulse: Bausch Health Issues Positive Pre-Announcement, Acorda Streamlines Operations
January 13, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
ZLAB
AFMD
Market News
From
Benzinga
Notable Tuesday Option Activity: JWN, ACRX, PCH
January 12, 2021
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Nordstrom, Inc. (JWN), where a total of 32,422 contracts have traded so far, representing...
Tags
Stocks
From
Market News Video
12 Health Care Stocks Moving In Tuesday's Intraday Session
January 12, 2021
Gainers Biolase (NASDAQ:BIOL) shares rose 40.29% to $0.81 during Tuesday's regular session. Biolase's stock is ...
Tags
JAGX
BZI/TFM
IRIX
From
Benzinga
AcelRx Pharmaceuticals Announces Publication of Clinical Data on Decreased Postoperative Opioid Requirements and Enhanced Postanesthesia Recovery Following Perioperative Use of DSUVIA®
December 10, 2020
AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today...
From
PR Newswire
AcelRx Announces $10 Million Registered Direct Common Stock Offering
December 10, 2020
Investment from existing and new, leading life sciences investors
From
PR Newswire
AcelRx Pharmaceuticals to Present at LD Micro Main Event
December 09, 2020
AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the use in medically supervised settings,...
From
PR Newswire
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.